News & Updates

Ponatinib in CML and Ph+ ALL: Long-term efficacy and safety

23 Jan 2024 by

Ponatinib is a highly potent agent recommended by international guidelines. Watch this video to gain insights from Dr Raymond Wong of the Division of Haematology, Department of Medicine & Therapeutics, Chinese University of Hong Kong, on ponatinib’s long-term data in chronic myeloid leukaemia (CML) and Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), and how to optimize its dose to improve risk-benefit profile.

Ponatinib in CML and Ph+ ALL: Long-term efficacy and safety

23 Jan 2024

Levetiracetam use during pregnancy poses no significant risks of birth defects, miscarriage

22 Jan 2024 by

Expectant mothers who use the antiseizure medication levetiracetam as monotherapy do not appear to have increased overall risk of major birth defects or miscarriage, as reported in a study.

Levetiracetam use during pregnancy poses no significant risks of birth defects, miscarriage

22 Jan 2024

Gabapentinoids up risk of severe COPD exacerbation

22 Jan 2024

Use of gabapentinoid can potentially elevate the risk for severe exacerbation in patients with chronic obstructive pulmonary disease (COPD), suggests a study.

Gabapentinoids up risk of severe COPD exacerbation

22 Jan 2024

Berdazimer gel reduces molluscum contagiosum lesions in children

22 Jan 2024 by

An analysis of three randomized controlled trials (RCTs) has shown the efficacy and safety of berdazimer gel, a topical, antiviral, nitric oxide-releasing medication, in the treatment of molluscum contagiosum (MC) lesions in patients aged 6 months and older. Application-site pain and erythema are the most common adverse events (AEs) related to treatment.

Berdazimer gel reduces molluscum contagiosum lesions in children

22 Jan 2024

Is night-time better than morning dosing of antihypertensives?

22 Jan 2024

Bedtime dosing of antihypertensive medication is neither better nor worse than morning dosing when it comes to the subsequent risk of all-cause or cardiovascular mortality, according to a study.

Is night-time better than morning dosing of antihypertensives?

22 Jan 2024

The 100,000 Genomes Project: Insights from the cancer programme

22 Jan 2024 by

Recently published data from the cancer programme of the 100,000 Genomes Project, which maps out the genomic patterns of patients with different cancer types using whole-genome sequencing (WGS), have provided insights on integrating genomics into routine cancer care.

The 100,000 Genomes Project: Insights from the cancer programme

22 Jan 2024

Cancer survivors may benefit from social media-based interventions

22 Jan 2024 by

A meta-analysis and meta-regression of randomized controlled trials (RCTs) found that social media-based interventions – which are interventions from any form of online medium that enables participant interaction (eg, Facebook, Instagram, TikTok, Twitter) – may be beneficial for cancer patients.

Cancer survivors may benefit from social media-based interventions

22 Jan 2024

Kidney function improvement with an SGLT2 inhibitor in an elderly patient with CKD and T2DM

22 Jan 2024 by

A 69-year-old male with a body mass index (BMI) of 27.3 kg/m²presented in April 2022 with overt macroalbuminuria that had persisted for 1.5 years. He had long-standing history of type 2 diabetes mellitus (T2DM; HbA_1c, 7.3 percent) and hypertension (systolic blood pressure [BP], 140–150 mm Hg) for >20 years, and was on antihypertensive treatment with losartan 100 mg QD, amlodipine 10 mg QD, metoprolol 100 mg BID, prazosin 2 mg BID, and methyldopa 250 mg BID as well as glucose-lowering medications with metformin 750 mg BID and gliclazide 80 mg BID.

Kidney function improvement with an SGLT2 inhibitor in an elderly patient with CKD and T2DM

22 Jan 2024

Use of low-dose edoxaban in a 99-year-old AF patient with comorbidities and comedications

22 Jan 2024 by

A 99-year-old Chinese female first presented in January 2022 with two episodes of sudden-onset transient left-sided weakness and dysarthria that resolved completely. At the age of 50 years, she was treated for pulmonary tuberculosis. She underwent resection of colon carcinoma at the age of 80 years and had remained in remission since.

Use of low-dose edoxaban in a 99-year-old AF patient with comorbidities and comedications

22 Jan 2024

Targeting the window of opportunity in management of hidradenitis suppurativa

22 Jan 2024 by

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with systemic comorbidities and diminished health-related quality of life (HRQoL). At the Hong Kong Society of Dermatology and Venereology Annual Scientific Meeting 2023, Dr Han-Chi Tseng of the Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, reviewed the burden of HS, evidence for treatment with secukinumab, and the potential for early treatment initiation to change the disease course.

Targeting the window of opportunity in management of hidradenitis suppurativa

22 Jan 2024

News & Updates

Filter by Specialty:

Specialty:

Ponatinib in CML and Ph+ ALL: Long-term efficacy and safety

Ponatinib in CML and Ph+ ALL: Long-term efficacy and safety

Levetiracetam use during pregnancy poses no significant risks of birth defects, miscarriage

Levetiracetam use during pregnancy poses no significant risks of birth defects, miscarriage

Gabapentinoids up risk of severe COPD exacerbation

Gabapentinoids up risk of severe COPD exacerbation

Berdazimer gel reduces molluscum contagiosum lesions in children

Berdazimer gel reduces molluscum contagiosum lesions in children

Is night-time better than morning dosing of antihypertensives?

Is night-time better than morning dosing of antihypertensives?

The 100,000 Genomes Project: Insights from the cancer programme

The 100,000 Genomes Project: Insights from the cancer programme

Cancer survivors may benefit from social media-based interventions

Cancer survivors may benefit from social media-based interventions

Kidney function improvement with an SGLT2 inhibitor in an elderly patient with CKD and T2DM

Kidney function improvement with an SGLT2 inhibitor in an elderly patient with CKD and T2DM

Use of low-dose edoxaban in a 99-year-old AF patient with comorbidities and comedications

Use of low-dose edoxaban in a 99-year-old AF patient with comorbidities and comedications

Targeting the window of opportunity in management of hidradenitis suppurativa

Targeting the window of opportunity in management of hidradenitis suppurativa